0.20 INR
−34.79 M INR
396.42 M INR
About OXYGENTA PHARMACEUTICAL LIMITE
Sector
CEO
Sai Sudhakar Vankineni
Headquarters
Hyderabad
Website
Founded
1990
ISIN
INE102E01018
FIGI
BBG000BZN4T4
Oxygenta Pharmaceutical Ltd. engages in the development and manufacture of bulk drugs. It offers anti-ulcerative and anti-bacterial drugs. The company was founded on November 27, 1990 and is headquartered in Hyderabad, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OXYGENTAPH is 90.14 INR — it has increased by 5.00% in the past 24 hours. Watch OXYGENTA PHARMACEUTICAL LIMITE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange OXYGENTA PHARMACEUTICAL LIMITE stocks are traded under the ticker OXYGENTAPH.
OXYGENTAPH stock has risen by 19.39% compared to the previous week, the month change is a −6.40% fall, over the last year OXYGENTA PHARMACEUTICAL LIMITE has showed a 192.57% increase.
OXYGENTAPH reached its all-time high on Oct 28, 2024 with the price of 108.64 INR, and its all-time low was 2.95 INR and was reached on Jul 22, 2008. View more price dynamics on OXYGENTAPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OXYGENTAPH stock is 4.76% volatile and has beta coefficient of −0.68. Track OXYGENTA PHARMACEUTICAL LIMITE stock price on the chart and check out the list of the most volatile stocks — is OXYGENTA PHARMACEUTICAL LIMITE there?
Today OXYGENTA PHARMACEUTICAL LIMITE has the market capitalization of 3.05 B, it has decreased by −11.25% over the last week.
Yes, you can track OXYGENTA PHARMACEUTICAL LIMITE financials in yearly and quarterly reports right on TradingView.
OXYGENTAPH net income for the last quarter is −28.54 M INR, while the quarter before that showed −13.63 M INR of net income which accounts for −109.34% change. Track more OXYGENTA PHARMACEUTICAL LIMITE financial stats to get the full picture.
No, OXYGENTAPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 5, 2024, the company has 161.00 employees. See our rating of the largest employees — is OXYGENTA PHARMACEUTICAL LIMITE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OXYGENTA PHARMACEUTICAL LIMITE EBITDA is −80.12 M INR, and current EBITDA margin is −24.40%. See more stats in OXYGENTA PHARMACEUTICAL LIMITE financial statements.
Like other stocks, OXYGENTAPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OXYGENTA PHARMACEUTICAL LIMITE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OXYGENTA PHARMACEUTICAL LIMITE technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OXYGENTA PHARMACEUTICAL LIMITE stock shows the buy signal. See more of OXYGENTA PHARMACEUTICAL LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.